Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest ABG-WTT Global Life Science Capital Partners GP Lt Stock Portfolio

$41.52Million

About ABG-WTT Global Life Science Capital Partners GP Lt and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, ABG-WTT Global Life Science Capital Partners GP Ltd reported an equity portfolio of $41.5 Millions as of 31 Mar, 2024.

The top stock holdings of ABG-WTT Global Life Science Capital Partners GP Ltd are , RPID, LUNG. The fund has invested 96.8% of it's portfolio in CG ONCOLOGY INC and 1.9% of portfolio in RAPID MICRO BIOSYSTEMS INC.

The fund managers got completely rid off RAYZEBIO INC and MEDAVAIL HOLDINGS (MDVL) stocks. ABG-WTT Global Life Science Capital Partners GP Ltd opened new stock positions in CG ONCOLOGY INC.
ABG-WTT Global Life Science Capital Partners GP Lt Equity Portfolio Value
Last Reported on: 15 May, 2024

New Buys

Ticker$ Bought
cg oncology inc40,190,500

New stocks bought by ABG-WTT Global Life Science Capital Partners GP Lt

Additions

No additions were made to existing positions by ABG-WTT Global Life Science Capital Partners GP Lt

Reductions

None of the existing positions were reduced by ABG-WTT Global Life Science Capital Partners GP Lt

Sold off

Ticker$ Sold
rayzebio inc-48,425,600
medavail holdings-1,349,640

ABG-WTT Global Life Science Capital Partners GP Lt got rid off the above stocks

ABG-WTT Global Life Science Capital Partners GP Lt Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ABG-WTT Global Life Science Capital Partners GP Lt

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions